NCT04533139View on ClinicalTrials.gov

Influenza Vaccine in Lung Transplant Patients - Antibody

CompletedOBSERVATIONAL

Enrollment

122

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Influenza

Interventions

DRUG

Influenza vaccine

"influenza vaccine 0.5 ml intramuscularly each season~2004-2005 season antigens: A/New Caledonia/20/99(H1N1)-like, A/Wyoming/3/2003(H3N2), and B/Shanghai/361/2002-like antigens~2005-2006 season antigens: A/New Caledonia/ 20/00(H1N1)-like, A/California/7/2004 (H3N2)-like, and B/Shanghai/361/2002-like antigens"

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors

lead

University of Wisconsin, Madison

OTHER

NCT04533139 - Influenza Vaccine in Lung Transplant Patients - Antibody | Biotech Hunter | Biotech Hunter